Peacock Thomas P, Sealy Joshua E, Harvey William T, Benton Donald J, Reeve Richard, Iqbal Munir
Department of Infectious Diseases, Imperial College London, UK, W2 1NY.
Avian Influenza Group, The Pirbright Institute, Woking, UK, GU24 0NF.
J Virol. 2021 Mar 1;95(5). doi: 10.1128/JVI.01651-20. Epub 2020 Dec 2.
Receptor recognition and binding is the first step of viral infection and a key determinant of host specificity. The inability of avian influenza viruses to effectively bind human-like sialylated receptors is a major impediment to their efficient transmission in humans and pandemic capacity. Influenza H9N2 viruses are endemic in poultry across Asia and parts of Africa where they occasionally infect humans and are therefore considered viruses with zoonotic potential. We previously described H9N2 viruses, including several isolated from human zoonotic cases, showing a preference for human-like receptors. Here we take a mutagenesis approach, making viruses with single or multiple substitutions in H9 haemagglutinin and test binding to avian and human receptor analogues using biolayer interferometry. We determine the genetic basis of preferences for alternative avian receptors and for human-like receptors, describing amino acid motifs at positions 190, 226 and 227 that play a major role in determining receptor specificity, and several other residues such as 159, 188, 193, 196, 198 and 225 that play a smaller role. Furthermore, we show changes at residues 135, 137, 147, 157, 158, 184, 188, and 192 can also modulate virus receptor avidity and that substitutions that increased or decreased the net positive charge around the haemagglutinin receptor-binding site show increases and decreases in avidity, respectively. The motifs we identify as increasing preference for the human-receptor will help guide future H9N2 surveillance efforts and facilitate our understanding of the emergence of influenza viruses with increased zoonotic potential. As of 2020, over 60 infections of humans by H9N2 influenza viruses have been recorded in countries where the virus is endemic. Avian-like cellular receptors are the primary target for these viruses. However, given that human infections have been detected on an almost monthly basis since 2015, there may be a capacity for H9N2 viruses to evolve and gain the ability to target human-like cellular receptors. Here we identify molecular signatures that can cause viruses to bind human-like receptors, and we identify the molecular basis for the distinctive preference for sulphated receptors displayed by the majority of recent H9N2 viruses. This work will help guide future surveillance by providing markers that signify the emergence of viruses with enhanced zoonotic potential as well as improving understanding of the basis of influenza virus receptor-binding.
受体识别与结合是病毒感染的第一步,也是宿主特异性的关键决定因素。禽流感病毒无法有效结合类人唾液酸化受体是其在人类中高效传播及具备大流行能力的主要障碍。H9N2流感病毒在亚洲及非洲部分地区的家禽中呈地方性流行,偶尔感染人类,因此被视为具有人畜共患病潜力的病毒。我们之前描述过H9N2病毒,包括从人类人畜共患病病例中分离出的几种病毒,它们表现出对类人受体的偏好。在此,我们采用诱变方法,构建在H9血凝素中具有单取代或多取代的病毒,并使用生物层干涉术检测其与禽类和人类受体类似物的结合情况。我们确定了对替代性禽类受体和类人受体偏好的遗传基础,描述了在190、226和227位的氨基酸基序在决定受体特异性方面起主要作用,以及其他几个如159、188、193、196、198和225位的残基起较小作用。此外,我们发现135、137、147、157、158、184、188和192位残基的变化也可调节病毒受体亲和力,并且血凝素受体结合位点周围净正电荷增加或减少的取代分别显示亲和力增加和降低。我们确定的增加对人类受体偏好的基序将有助于指导未来的H9N2监测工作,并促进我们对具有增强人畜共患病潜力的流感病毒出现的理解。截至2020年,在该病毒地方性流行的国家已记录到60多例人类感染H9N2流感病毒的病例。类禽细胞受体是这些病毒的主要靶标。然而,鉴于自2015年以来几乎每月都检测到人类感染病例,H9N2病毒可能有能力进化并获得靶向类人细胞受体的能力。在此,我们确定了可使病毒结合类人受体的分子特征,并确定了大多数近期H9N2病毒对硫酸化受体独特偏好的分子基础。这项工作将通过提供标志着具有增强人畜共患病潜力病毒出现的标志物以及增进对流感病毒受体结合基础的理解来帮助指导未来的监测工作。